Sanofi-Aventis and Scripps Genomic Medicine (SGM) entered a strategic alliance to advance R&D initiatives in the field of personalized medicine. Under the alliance, SA’s R&D unit will fund as many as three discovery innovation grants per year, aimed at providing flexible financing for research proposals from Scripps investigators. In turn, SA will be granted non-exclusive rights to any research tools developed through these grants, as well as access to Scripps lab facilities in suppor...